ClinicalTrials.gg
Drug

Lubiprostone clinical trials

Also written Amitiza.

studies test it
47
open now
2
in phase 3
22
first study started
2005

How each study uses Lubiprostone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Lubiprostone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 Jan 2006 · AMITIZA · NDA 021908 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lubiprostone
40
Brand name: Amitiza
2

Brand

Amitiza
28

Studies by the year they started

47 studies that test it; most in 2007 (7)

Studies that test Lubiprostone, by start year
YearStudies
20052
20077
20086
20095
20107
20113
20122
20133
20141
20151
20165
20171
20191
20201
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
5
Phase 3
22
Phase 4
12
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 28

Sucampo Pharma Americas, LLC (13) · Takeda (3) · University of South Alabama (2) · Augusta University (2) · Texas Tech University Health Sciences Center, El Paso (2) · Mayo Clinic (2) · Brooke Army Medical Center (2) · University of Arkansas (2)

Often tested with

Tested in the same studies.

Polyethylene Glycols (1) · Polyethylene glycol 3350 (1) · Bisacodyl (1) · Golytely (1) · Maintenance Therapy (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Lubiprostone, phase 3 first.

Studies

Open first, then newest update. How each study uses Lubiprostone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 47

See all 47 studies that test Lubiprostone →

As the comparator · 1 — what is tested is compared with Lubiprostone

Codes

What other systems call Lubiprostone · ClinicalTrials.gg INT006502

  • MeSH (NLM) D000068238LubiprostoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7662KG2R6KLUBIPROSTONEConfirmed FDA, NLM, Wikidata
  • RxNorm 623033Confirmed FDA, Wikidata
  • Wikidata Q6695342lubiprostoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66040LubiprostoneConfirmed FDA, Wikidata
  • DrugBank DB01046One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.